1. Home
  2. RXRX vs FSK Comparison

RXRX vs FSK Comparison

Compare RXRX & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.11

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

FSK

FS KKR Capital Corp.

HOLD

Current Price

$10.48

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXRX
FSK
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
RXRX
FSK
Price
$3.11
$10.48
Analyst Decision
Buy
Hold
Analyst Count
4
8
Target Price
$7.50
$13.94
AVG Volume (30 Days)
11.6M
4.1M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
19.88%
EPS Growth
14.79
N/A
EPS
N/A
0.04
Revenue
$74,681,000.00
N/A
Revenue This Year
$12.11
N/A
Revenue Next Year
$82.52
N/A
P/E Ratio
N/A
$252.88
Revenue Growth
26.92
N/A
52 Week Low
$2.80
$9.72
52 Week High
$7.18
$22.68

Technical Indicators

Market Signals
Indicator
RXRX
FSK
Relative Strength Index (RSI) 40.42 45.29
Support Level $2.98 $10.28
Resistance Level $5.03 $10.56
Average True Range (ATR) 0.17 0.35
MACD 0.00 0.14
Stochastic Oscillator 42.57 91.62

Price Performance

Historical Comparison
RXRX
FSK

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

Share on Social Networks: